Diurnal Looking To Secure US Partner Soon For Alkindi
Hypogonadism Capsule Also Promising
With its adrenal insufficiency therapy Alkindi getting established in Europe, the UK biotech is in partnering discussions in the US where approval is expected before the end of the year.
